ArticleCardiovascular diabetology2015

Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice.

Tao-Cheng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.